[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-341385-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-341385-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","ikbip-promotes-tumor-development-via-the-akt-signaling-pathway-in-esophageal-squamous-cell-carcinoma","IKBIP promotes tumor development via the AKT signaling pathway in esophageal squamous cell carcinoma","","Esophageal squamous cell carcinoma (ESCC) is a prevalent cancer with unclear molecular drivers and limited predictive biomarkers. This study investigates inhibitor of kappa B kinase interacting protein (IKBIP) expression in ESCC and defines its mechanisms. Multiple cancer databases, immunohistochemistry, survival statistics, Cox regression, functional assays with IKBIP knockdown or overexpression, Western blotting, AKT activation validation with LY-294002, and a xenograft model were used.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/ikbip-promotes-tumor-development-via-the-akt-signaling-pathway-in-esophageal-squamous-cell-carcinoma/341385/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/ikbip-promotes-tumor-development-via-the-akt-signaling-pathway-in-esophageal-squamous-cell-carcinoma/341385.png","ImageObject",300,407,{"name":42,"@type":43},"Aria","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-05","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",5,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the primary aim of the study on IKBIP in ESCC?","Question",{"text":63,"@type":64},"To determine the role of IKBIP in ESCC and clarify the underlying molecular mechanisms, especially its relationship with AKT signaling.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was IKBIP expression and patient relevance assessed?",{"text":68,"@type":64},"mRNA expression was analyzed using multiple cancer databases, and IKBIP protein levels were measured in ESCC and adjacent normal tissues by immunohistochemistry, followed by Kaplan–Meier survival and Cox regression analyses.",{"name":70,"@type":61,"acceptedAnswer":71},"What biological effects does IKBIP have on ESCC cells and tumors?",{"text":72,"@type":64},"IKBIP knockdown inhibited ESCC cell proliferation and migration, induced apoptosis, and caused G1/S phase arrest, while IKBIP overexpression activated AKT signaling and increased proliferation and migration; xenograft results showed tumor-promoting effects in mice.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},341385,1790197774,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,100,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Comic",60,"comic",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},6,"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":55,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":108,"preview_page_count":33,"preview_urls":145},2336464648322,"https://ap-avatar.wpscdn.com/avatar/2200025388227c56fec?_k=1778556882303663488","Hu etal. BMC Cancer (2024) 24:759 BMC Cancer  \n[https://doi.org/10.1186/s12885-024-12510-4](https://doi.org/10.1186/s12885-024-12510-4)  \nRESEARCH Open Access  \nIKBIP promotes tumor development via the akt signaling pathway in esophageal squamous cell carcinoma  \nJiannan Hu 1†, Chuanjing Dai 1†, Zhaoji Ding 1†, Yixiao Pan 1, Lingxiao Lu 1, Jiaqian Bao 1 and Jingmin Zheng 1*  \nAbstract  \nBackground Esophageal squamous cell carcinoma (ESCC) is one of the most common cancers worldwide. Inhibitor of kappa B kinase interacting protein (IKBIP) has been reported to promote glioma progression, but its role in other cancers remains unclear. This study aimed to investigate the role of IKBIP and its underlying molecular mechanisms in ESCC.  \nMethods The mRNA expression of IKBIP was analyzed using multiple cancer databases. Immunohistochemistry was performed to detect IKBIP protein expression in ESCC tissues and adjacent normal tissues, and Kaplan‒Meier survival and Cox regression analyses were carried out. The effects of IKBIP knockdown (or overexpression) on ESCC cells were detected by cell viability, cell migration, flow cytometry and Western blot assays. LY-294002 was used to validate the activation of the AKT signaling pathway by IKBIP. Finally, the role of IKBIP in ESCC was verified in a xenograft model. Results Both bioinformatics analysis and immunohistochemistry indicated that IKBIP expression in ESCC tissues was significantly increased and was associated with the prognosis of ESCC patients. In vitro experiments revealed that IKBIP knockdown significantly inhibited the proliferation and migration of ESCC cells, and induced cell apoptosis and G1/S phase arrest. Molecular mechanism results showed that the AKT signaling pathway was further activated after IKBIP overexpression, thereby increasing the proliferation and migration abilities of ESCC cells. In vivo study confirmed that IKBIP promoted the initiation and development of ESCC tumors in mice.  \nConclusions IKBIP plays a tumor-promoting role in ESCC and may serve as a predictive biomarker and a potential therapeutic target for ESCC.  \nKeywords AKT, ESCC, IKBIP, Prognosis, Tumor-promoting  \n†Jiannan Hu and Chuanjing Dai contributed equally to this work.  \n*Correspondence: Jingmin Zheng [zzjjmm7713@sina.com](zzjjmm7713@sina.com)  \n1Department of Public Laboratory, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, 150 Ximenjie, Linhai, Zhejiang Province 317000, China  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/l](http://creativecommons.org/l)icenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ([http://creativecommons.org/publicdomain/zero/1.0/](http://creativecommons.org/publicdomain/zero/1.0/)) applies to the data made available in this article, unless otherwise stated in a credit line to the data.  \nHu et al. BMC Cancer (2024) 24:759  \nIntroduction  \nEsophageal cancer (ESCA) has become a common malignant tumor worldwide [1]. According to the cancer burden data, the number of ESCA deaths worldwide reached 187,500 in 2022, ranking fifth among malignant tumor deaths [2]. Esophageal squamous cell carcinoma (ESCC) is the main histological","cbCaik6FNJM7RPPZ","https://ap.wps.com/l/cbCaik6FNJM7RPPZ","pdf",10527276,16,"English","# Introduction\n## Background and rationale\n## Prior knowledge on IKBIP","[{\"question\":\"What is the primary aim of the study on IKBIP in ESCC?\",\"answer\":\"To determine the role of IKBIP in ESCC and clarify the underlying molecular mechanisms, especially its relationship with AKT signaling.\"},{\"question\":\"How was IKBIP expression and patient relevance assessed?\",\"answer\":\"mRNA expression was analyzed using multiple cancer databases, and IKBIP protein levels were measured in ESCC and adjacent normal tissues by immunohistochemistry, followed by Kaplan–Meier survival and Cox regression analyses.\"},{\"question\":\"What biological effects does IKBIP have on ESCC cells and tumors?\",\"answer\":\"IKBIP knockdown inhibited ESCC cell proliferation and migration, induced apoptosis, and caused G1/S phase arrest, while IKBIP overexpression activated AKT signaling and increased proliferation and migration; xenograft results showed tumor-promoting effects in mice.\"}]","IKBIP promotes tumor development via the AKT signaling pathway in esophageal squamous cell carcinoma | PDF",1790041706,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/09f55b23f735b23680a026122a7b866d.webp",983,1310,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/167d70f98ebd7dffffbeac09c031a429.webp",982,1309,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/58f112cdb756009669851da846e779e7.webp",981,1308,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4a2b20860a057f94dd46900006ab06f5.webp",980,1306]